Menu
image description

Tag: baricitinib

ACR|ARHP News on Potential New Lupus Treatments

The Lupus Research Alliance was on the ground at the American College of Rheumatology 2018 meeting to bring you the latest news in lupus research and translation.  Several clinical trials showed benefits of potential new treatments for helping people with lupus. Following are summaries of the stand-out results: Ustekinumab (Stelara®) A Phase 2 controlled study compared […] Read More

Baricitinib Shows Positive Results for SLE in Phase 2 Study

June 19, 2018 Once-daily oral baricitinib 4 mg was associated with significant clinical improvements compared with placebo in patients with systemic lupus erythematosus (SLE) receiving standard background therapy, according to data presented at the European League Against Rheumatism (EULAR) Congress held in Amsterdam, June 13 to 16, 2018…. A significantly greater percentage of patients in the […] Read More

because the Lupus Research Alliance board of directors funds all administrative and fundraising costs